Correcting hazard ratio estimates for outcome misclassification using multiple imputation with internal validation data

Pharmacoepidemiology and Drug Safety
Jiayi NiElham Rahme

Abstract

Outcome misclassification may occur in observational studies using administrative databases. We evaluated a two-step multiple imputation approach based on complementary internal validation data obtained from two subsamples of study participants to reduce bias in hazard ratio (HR) estimates in Cox regressions. We illustrated this approach using data from a surveyed sample of 6247 individuals in a study of statin-diabetes association in Quebec. We corrected diabetes status and onset assessed from health administrative data against self-reported diabetes and/or elevated fasting blood glucose (FBG) assessed in subsamples. The association between statin use and new onset diabetes was evaluated using administrative data and the corrected data. By simulation, we assessed the performance of this method varying the true HR, sensitivity, specificity, and the size of validation subsamples. The adjusted HR of new onset diabetes among statin users versus non-users was 1.61 (95% confidence interval: 1.09-2.38) using administrative data only, 1.49 (0.95-2.34) when diabetes status and onset were corrected based on self-report and undiagnosed diabetes (FBG ≥ 7 mmol/L), and 1.36 (0.92-2.01) when corrected for self-report and undiagnosed diabetes...Continue Reading

References

May 1, 1977·American Journal of Epidemiology·K T CopelandR H Holbrook
Mar 1, 1983·International Journal of Epidemiology·S Greenland, D G Kleinbaum
Sep 15, 1995·Statistics in Medicine·P W LavoriD Shera
Jul 15, 1997·American Journal of Epidemiology·L S Magder, J P Hughes
Jun 27, 2000·Diabetes/metabolism Research and Reviews·S J GriffinN J Wareham
Nov 6, 2001·Annals of Internal Medicine·L S PhillipsC S Barnes
Jun 14, 2002·Diabetes Research and Clinical Practice·David W DunstanUNKNOWN Australian Diabetes, Obesity and Lifestyle Study (AusDiab)
Sep 5, 2002·Statistics in Medicine·Georg Heinze, Michael Schemper
Feb 1, 2003·Diabetes Research and Clinical Practice·Florentino CarralLuis Escobar
Mar 1, 2003·Diabetes Care·Jaana Lindström, Jaakko Tuomilehto
Jul 1, 1962·American Journal of Public Health and the Nation's Health·E L DIAMOND, A M LILIENFELD
May 13, 2005·Statistics in Medicine·Xianqun LuanBradley P Carlin
Jul 1, 2005·American Journal of Epidemiology·Til StürmerRobert J Glynn
Aug 23, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Wolfgang C WinkelmayerDaniel H Solomon
Sep 21, 2005·International Journal of Epidemiology·Matthew P FoxSander Greenland
May 20, 2006·International Journal of Epidemiology·Stephen R ColeSander Greenland
Jun 19, 2008·Journal of Epidemiology and Community Health·G Maldonado
Oct 22, 2008·Statistics in Medicine·Karen Messer, Loki Natarajan
Jan 12, 2011·Annual Review of Public Health·Douglas P JutteMarni D Brownell
Jun 23, 2011·JAMA : the Journal of the American Medical Association·David PreissKausik K Ray
Jan 11, 2012·Archives of Internal Medicine·Annie L CulverYunsheng Ma
Oct 18, 2012·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Kevin PottieUNKNOWN Canadian Task Force on Preventive Health Care
May 10, 2013·Diabetes Care·Aaron LeongElham Rahme
May 16, 2014·Canadian Journal of Diabetes·Ronald GoldenbergZubin Punthakee
Mar 15, 2014·American Journal of Epidemiology·Jessie K EdwardsDavid B Richardson

❮ Previous
Next ❯

Citations

Oct 2, 2020·Statistical Methods in Medical Research·Bas Bl Penning de VriesRolf Hh Groenwold

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.